Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-032815
Filing Date
2024-08-16
Accepted
2024-08-16 16:05:31
Documents
52
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 799937
2 ex31-1.htm EX-31.1 17394
3 ex31-2.htm EX-31.2 17217
4 ex32-1.htm EX-32.1 7555
5 ex32-2.htm EX-32.2 7553
  Complete submission text file 0001493152-24-032815.txt   4711107

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pwup-20240630.xsd EX-101.SCH 43752
7 XBRL CALCULATION FILE pwup-20240630_cal.xml EX-101.CAL 31518
8 XBRL DEFINITION FILE pwup-20240630_def.xml EX-101.DEF 234345
9 XBRL LABEL FILE pwup-20240630_lab.xml EX-101.LAB 307182
10 XBRL PRESENTATION FILE pwup-20240630_pre.xml EX-101.PRE 258400
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 646009
Mailing Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038
Business Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038 561-704-8527
PowerUp Acquisition Corp. (Filer) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41293 | Film No.: 241216701
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)